Bio-Techne Corporation (NASDAQ:TECH) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2025.
Bio-Techne Corp (TECH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Select Equity Group Robert Joseph Caruso | 1,839,955 | $147,067,603 | -27% | 0.52% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,762,794 | $140,900,124 | -12% | 0.17% |
| 3. | Millennium Management Israel Englander | 1,271,941 | $101,666,244 | +14% | 0.04% |
| 4. | Citadel Investment Group Ken Griffin | 1,204,484 | $96,274,406 | +367% | 0.01% |
| 5. | Point72 Asset Management Steve Cohen | 1,122,527 | $89,723,574 | 0.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $352.55 | 300 | 10,106 | 2022-05-10 | Filing | ||
| $185.00 | 100 | Officer, Director | 100 | 2019-09-09 | Filing | |
| $185.00 | 100 | Officer, Director | 100 | 2019-09-09 | Filing | |
| $191.06 | 500 | Director | 8,726 | 2019-08-07 | Filing | |
| $65.00 | 2,361 | Director | 70,000 | 2013-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.10 | 16,000 | Director | 43,401 | 2024-08-08 | Filing | |
| $83.84 | 4,000 | Director | 36,608 | 2024-05-14 | Filing | |
| $76.98 | 10,400 | Director | 43,097 | 2024-03-07 | Filing | |
| $80.32 | 8,939 | Director | 51,872 | 2023-08-30 | Filing | |
| $88.36 | 80,000 | Officer, Director | 1,258,766 | 2023-07-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,228,210 | $1,406,488,683 | 0.03% | |
| 2. | 18,133,912 | $1,399,212,623 | 0.03% | |
| 3. | 6,328,129 | $488,278,434 | 0.02% | |
| 4. | 5,352,006 | $412,960,783 | 1.09% | |
| 5. | 4,088,095 | $315,437,590 | 0.02% |
News See All
Here’s What Dragged Bio-Techne Corporation (TECH)?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter.
Bio-Techne Corporation (NASDAQ:TECH) Q4 2024 Earnings Call Transcript
Operator: [Call Starts Abruptly] Call for the Fourth Quarter of Fiscal Year 2024.
Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
What Makes Bio-Techne Corporation (TECH) an Investment Bet?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript
Bio-Techne Corporation misses on earnings expectations. Reported EPS is $0.4 EPS, expectations were $0.42.